InsidersTradesSigma
Follow the Shanghai Junshi Biosciences Co., Ltd. stock price and the full insider trade history of the company, a publicly traded company based in Hong Kong. Shares are quoted on the HK market, under the oversight of HKEX. Operating in the Health Care sector, Shanghai Junshi Biosciences Co., Ltd. has recorded 5 insider filings. Market capitalisation: €18.7bn. The latest transaction was reported on 8 April 2026 (Purchase). Among the most active insiders: Xiong Jun. All data is openly available.
5
Insider Decl.
n/a
Thresholds
€11m
5 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Shanghai Junshi Biosciences Co., Ltd. Strong Buy (bullish), based on 4 analysts. Average price target: HK$28.93.
15Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 23,560 of 28,835 companies
29.4
score / 100
Value21
Quality38
FCF yld-6.8%
Earn yld-4.5%
EV/EBITDA·
ROE-13%
Gross mgn79%
Net mgn-34%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 8 April 2026
Declarations5 total
894,600 sharesShareXHKGHKEX:DA20260403E00027
1,999,513 sharesShareXHKGHKEX:DA20260403E00026
5 of 5 declarations
About Shanghai Junshi Biosciences Co., Ltd.
Shanghai Junshi Biosciences Co., Ltd. is a biopharmaceutical company focused on the research and development of innovative drugs. It specializes in biological therapies for the treatment of serious diseases.